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Cultures of lapme articular chondrocytes were exposed to purified, human, recombmant interleukin-la or partially purified preparations of lapine. 
synovial, cytokines in the presence of P2P]orthophosphate. After 30 min incubation, phosphoproteins were extracted from the cells, separated by 
two-dimensional gel electrophoresis and visualized autoradiographically. Analysis of the autoradiograms revealed that interleukin-1 and the syno- 
vial factors produced marked changes in the pattern of protein phosphorylation. The synovial cytokines induced many of the same changes as 
mterleukin-1, as well as a number of unique changes. This finding is consistent with the notion that, in addition to interleukin-1, synoviocytes 
secrete other cytokines which modulate the metabolism of chondrocytes. These data support the idea that signal transduction in chondrocytes 
responding to mterleukin-1 involves the activation of one or more protein kinases. 
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1. INTRODUCTION 
Articular chondrocytes undergo a process of activa- 
tion following treatment with interleukin-1 (IL-l). 
Cultures of activated chondrocytes synthesize and 
secrete large amounts of prostaglandin EZ (PGE2) and 
various neutral proteinases [l-4], while their synthesis 
of matrix constituents is concomitantly suppressed 
[5,6]. Such changes may underlie the ability of IL-l to 
induce the autolytic digestion of living cartilage both in 
vivo [7] and in vitro [l]. These processes are likely to 
occur during the development of arthritis, leading to 
erosion of the articular surfaces. 
Synovium is a major intraarticular source of IL-l. 
Although macrophages [8] and polymorphonuclear 
leukocytes [9-l l] contribute to the synovial production 
of IL-l during inflammatory episodes, the resident 
synovial fibroblasts also secrete appreciable amounts of 
this cytokine [4,12,13]. Moreover, we have proposed 
that, in addition to IL-l, synoviocytes secrete other 
cytokines which modulate the activation state of chon- 
drocytes [ 141. For convenience, these unfractionated 
mixtures of synovial cytokines are referred to as 
chondrocyte-activating factors (CAF) [4,12]. 
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Although the physiological responses to IL-l have 
been widely studied, little is known of the signal 
transduction mechanisms involved. IL-la and IL-I,# 
share a common cell surface receptor [ 15,161, but no se- 
cond messenger has yet been clearly identified. In 
preliminary experiments it has not proved possible to 
link CAMP or Ca2+ to the induction of neutral 
metalloproteinases in chondrocytes [ 121. However, 
IL-l increases intracellular concentrations of CAMP in 
lymphocytes and fibroblasts [17,18], generates inositol 
triphosphate in macrophages [19] and stimulates the 
production of diacylglycerol in Jurkat cells [20]. It re- 
mains possible that certain cellular responses to IL-l 
are mediated through novel signalling mechanisms. 
As all known signal transduction mechanisms at 
some stage activate a protein kinase, we thought it per- 
tinent at this stage to determine whether IL-l and CAF 
alter the pattern of protein phosphorylation in chon- 
drocytes. Only two other published articles report the 
changes in protein phosphorylation in response to IL-l. 
Both of these involve white cells [21,22]. 
2. EXPERIMENTAL 
2.1. Reagents 
The following reagents were purchased from the indicated sup- 
pliers: interleukin-lcu (Genzyme, Boston, MA); tissue culture media, 
sera, antibiotics, etc. (Gibco, Grand Island, NY); tissue culture 
plasticware (Fisher Scientific, Pittsburgh, PA); young adult New 
Zealand white rabbits (Green Meadows Rabbitry, Murrysville, PA); 
[“Plorthophosphate (New England Nuclear, Boston, MA); elec- 
trophoretic equipment and supplies (BioRad, Richmond, CA). 
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Monolayer cultures of articular chondrocytes were prepared from 
the knee and shoulder joints of New Zealand white rabbits, as 
described by Green 1231. Cells were seeded into 24-well plates or 
35 mm Petri dishes, at a concentration of 10’ cells per cm’, and used 
when confluent, without subculture. Synovial CAF was prepared 
from cultures of the HIG-82 synovial cell line [24] as described 
elsewhere 1121. 
Growth medium was removed and, after washing the cell sheet 
twice with Gey’s solution, replaced by phosphate-free minimal essen- 
tial medium without serum. Cells were metabolically labelled with 
2OO~Ci/ml ‘*P-orthophosphate for 3.5 h, after which time IL-la! 
(20 U/ml) or CAF (25 ,&‘mt; 200 fig protein) were added to certain 
cultures. All cultures were returned to the incubator for a further 
30 min. Media were then removed, the cell sheet washed twice with 
ice-cold Gey’s solution and processed for two-dimensional gel elec- 
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trophoresis, according to the method of O’FarrelI [25], using a pf 
range from pH 3-10 in the first dimension, and a .5-15% 
polya~rylamide gradient in the second. 
These studies revealed multiple effects of IL-1 and CAF on the pat- 
terns of phosphoproteins (data not shown). As these changes were 
too complex for resolution by eye, triplicate sampfes were sent to 
Protein Databases Inc. (Huntington Station, New York) for analysis. 
Autora~ograms were scanned with an Eikonix 78/99 camera system, 
and the images processed with the PDQUEST computer analysis bas- 
ed upon the initial design and algorithms of Garrels et al. 126). 
3. RESULTS AND DISCUSSION 
Representative autoradiograms are shown in fig. 1. 
Two-dimensional geIs prepared from unactivated, con- 
trol chondr~c~e~ contained 845 different 32P-labelfed 
spots that could be distinguished by computer analysis 
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Fig.1. representative autoradiogr~ms of 2D gels prepared with 32P- 
phosphoproteins extracted from (a) control chondrocytes, (b) 
chondrocytes treated with IL-I and (c) chondrotytes treated with 
synovial CAF. Certain new spots induced both by XL-1 and CAF are 
marked by solid arrows in b and c, Certain additional spots induced 
by CAF, but not IL-1 are marked by open arrows in c. Certain spots 
extinguished by IL-1 and CAF are marked by a dotted arrow in a. 
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Fig.2. Differences between autoradiograms are shown on these computer-generated charts. The size of each circle is indicative of the magnitude 
of the difference. (a) Control vs IL-l; (b) control vs CAF; (c) IL-l vs CAF. 
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of the autoradiograms. Addition of IL-1 or CAF induc- 
ed a number of new phosphoproteins, while certain 
phosphoproteins were observed only in material ex- 
tracted from control cells (fig.1). 
Comparison of triplicate autoradiograms prepared 
from control chondroc~es and chondrocytes treated 
with IL-I, revealed 45 statistically significant (P < 0.05) 
differences (fig.2a). Comparison of autoradiograms 
prepared from control chondrocytes and chondrocytes 
treated with CAF revealed 53 differences (fig.2b). As 
indicated in fig.lb and c, many of these differences 
were common to cells treated with IL-1 and CAF 
(fig.2c). However, there were 28 differences between 
the phosphoprotein patterns produced by IL-l and 
CAF. These data are consistent with the notion that 
synovial CAF consists of IL-l together with additional 
cytokines which produce their own alterations in 
cellular phosphoproteins. 
The differences produced by IL-1 and CAF 
presumably reflect changes in the activities of one or 
more protein kinases or phosphatases in chondrocytes. 
The magnitude and rapidity of the changes render 
unlikely more complicated explanations based, for ex- 
ample, upon the induction of new proteins or altered 
substrate availability. Future investigations hould be 
directed towards identifying the kinases or 
phosphatases responsible for these changes and deter- 
mining their role in signal transduction. In preliminary 
experiments, we have not found inhibitors of protein 
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kinase C to inhibit the ability of IL-l to increase the 
synthesis of PGEz and neutral metalloproteinases by 
chondrocytes 1271. 
NOTE ADDED IN PROOF 
Kaur and Saklatvala (FEBS Lett. (1988) 241, 6-IO), 
studying protein phosphorylation in human dermal 
fibroblasts exposed to IL-lo and TNF-(Y, reported 
similar results to ours. In particular, there is a striking 
resemblance between their ‘triad of 27 kDa phospho- 
proteins (pf 6.0, 5.7 and 5.5)’ and the similar, if not 
identical, triad appearing on our 2-D gels. The most 
acidic of these three proteins, each of which is 
phosphorylated in response to IL-1 and CAF, is arrow- 
ed in our figs lb and c. 
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